Frontiers in Endocrinology · 2013 · 261 citations · 90 references
Life SciencesBiochemistryOncologyGlycobiologyMetabolismMolecular OncologyCancer GlycobiologyCancer MetabolismGlycosylation PathwaysO-linked GlycosylationOncogene ActivationOncology NutritionAberrant Glycosylation In CancerAberrant O-glycosylation In CancerCancer Cell Proliferation InhibitionCell Cycle-driven Tumor ProgressionGlucose ConcentrationO-glcnacylation In CancerO-linked N-acetylglucosamine ModificationProtein Glycosylation In Oncogenesis
O-linked N-acetylglucosaminylation (O-GlcNAcylation) is a reversible post-translational modification consisting in the addition of a sugar moiety to serine/threonine residues of cytosolic or nuclear proteins. Catalyzed by O-GlcNAc-transferase (OGT) and removed by O-GlcNAcase, this dynamic modification is dependent on environmental glucose concentration. O-GlcNAcylation regulates the activities of a wide panel of proteins involved in almost all aspects of cell biology. As a nutrient sensor, O-GlcNAcylation can relay the effects of excessive nutritional intake, an important cancer risk factor, on protein activities and cellular functions. Indeed, O-GlcNAcylation has been shown to play a significant role in cancer development through different mechanisms. O-GlcNAcylation and OGT levels are increased in different cancers (breast, prostate, colon…) and vary during cell cycle progression. Modulating their expression or activity can alter cancer cell proliferation and/or invasion. Interestingly, major oncogenic factors have been shown to be directly O-GlcNAcylated (p53, MYC, NFκB, β-catenin…). Furthermore, chromatin dynamics is modulated by O-GlcNAc. DNA methylation enzymes of the Tet family, involved epigenetic alterations associated with cancer, were recently found to interact with and target OGT to multi-molecular chromatin-remodeling complexes. Consistently, histones are subjected to O-GlcNAc modifications which regulate their function. Increasing number of evidences point out the central involvement of O-GlcNAcylation in tumorigenesis, justifying the attention received as a potential new approach for cancer treatment. However, comprehension of the underlying mechanism remains at its beginnings. Future challenge will be to address directly the role of O-GlcNAc-modified residues in oncogenic-related proteins to eventually propose novel strategies to alter cancer development and/or progression.
90
Proceedings of the National Academy of Sciences
2024 · 4.2K citations · Full text
Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine
Shinsuke Ito, Li Shen, Qing Dai et al. · Science · 2011 · 3.4K citations
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Florian R. Greten, Lars Eckmann, Tim F. Greten et al. · Cell · 2004 · 2.4K citations · Full text
Medicine, Immunology, Oncology +16
Caloric Restriction Delays Disease Onset and Mortality in Rhesus Monkeys
Ricki J. Colman, Rozalyn M. Anderson, Sterling C. Johnson et al. · Science · 2009 · 2.3K citations · Full text